[HTML][HTML] Glioma–Immune Cell Crosstalk in Tumor Progression
Simple Summary The environment surrounding primary glioma brain tumors plays a critical
role in tumor development and progression. Immune cells are important constituents of this …
role in tumor development and progression. Immune cells are important constituents of this …
[HTML][HTML] The Use of Targeted Cytokines as Cancer Therapeutics in Glioblastoma
M Sooreshjani, S Tripathi, C Dussold, H Najem… - Cancers, 2023 - mdpi.com
Simple Summary Despite multi-modal treatment consisting of surgery, chemotherapy, and
radiation, glioblastoma inevitably recurs due to its diffuse infiltrative nature. Anti-tumor …
radiation, glioblastoma inevitably recurs due to its diffuse infiltrative nature. Anti-tumor …
[HTML][HTML] Glioblastoma-on-a-chip construction and therapeutic applications
Z Xie, M Chen, J Lian, H Wang, J Ma - Frontiers in Oncology, 2023 - frontiersin.org
Glioblastoma (GBM) is the most malignant type of primary intracranial tumor with a median
overall survival of only 14 months, a very poor prognosis and a recurrence rate of 90%. It is …
overall survival of only 14 months, a very poor prognosis and a recurrence rate of 90%. It is …
The spatial and single-cell analysis reveals remodeled immune microenvironment induced by synthetic oncolytic adenovirus treatment
Oncolytic viruses are multifaceted tumor killers, which can function as tumor vaccines to
boost systemic antitumor immunity. In previous study, we rationally designed a synthetic …
boost systemic antitumor immunity. In previous study, we rationally designed a synthetic …
[HTML][HTML] Lipid-based nanoparticles to address the limitations of GBM therapy by overcoming the blood-brain barrier, targeting glioblastoma stem cells, and …
C Zhao, X Zhu, J Tan, C Mei, X Cai, F Kong - Biomedicine & …, 2024 - Elsevier
Glioblastoma multiforme (GBM) is the most common primary malignant brain tumor,
characterized by high heterogeneity, strong invasiveness, poor prognosis, and a low …
characterized by high heterogeneity, strong invasiveness, poor prognosis, and a low …
Targeting one‐carbon metabolism for cancer immunotherapy
X Ren, X Wang, G Zheng, S Wang… - Clinical and …, 2024 - Wiley Online Library
Abstract Background One‐carbon (1C) metabolism is a metabolic network that plays
essential roles in biological reactions. In 1C metabolism, a series of nutrients are used to …
essential roles in biological reactions. In 1C metabolism, a series of nutrients are used to …
Cell-based therapies for glioblastoma: Promising tools against tumor heterogeneity
D Nehama, AS Woodell, SM Maingi… - Neuro …, 2023 - academic.oup.com
Glioblastoma (GBM) is a highly aggressive tumor with a devastating impact on quality-of-life
and abysmal survivorship. Patients have very limited effective treatment options. The …
and abysmal survivorship. Patients have very limited effective treatment options. The …
Treatment options for advanced hepatocellular carcinoma: the potential of biologics
F Rossari, S Foti, S Camera, M Persano… - Expert Opinion on …, 2024 - Taylor & Francis
Introduction Advanced hepatocellular carcinoma (HCC) represents a significant global
health burden, whose treatment has been recently revolutionized by the advent of biologic …
health burden, whose treatment has been recently revolutionized by the advent of biologic …
[HTML][HTML] The role of tumor microenvironment in drug resistance: emerging technologies to unravel breast cancer heterogeneity
V Salemme, G Centonze, L Avalle, D Natalini… - Frontiers in …, 2023 - frontiersin.org
Breast cancer is a highly heterogeneous disease, at both inter-and intra-tumor levels, and
this heterogeneity is a crucial determinant of malignant progression and response to …
this heterogeneity is a crucial determinant of malignant progression and response to …
[HTML][HTML] Harnessing lentiviral vectors for in vivo gene therapy of liver metastases
G Giacca, L Naldini, ML Squadrito - Clinical and Translational …, 2024 - ncbi.nlm.nih.gov
Liver metastases (LMS) commonly arise from gastrointestinal tumors, such as colorectal
cancer (CRC) and pancreatic cancer (PDAC). The immunosuppressive environment of the …
cancer (CRC) and pancreatic cancer (PDAC). The immunosuppressive environment of the …